Flavanol-Rich Cocoa and Cerebral Blood Flow

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2012 by Brigham and Women's Hospital.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
MasterFoods
Information provided by (Responsible Party):
Naomi DL Fisher, MD, Brigham and Women's Hospital
ClinicalTrials.gov Identifier:
NCT00825695
First received: January 20, 2009
Last updated: April 20, 2012
Last verified: April 2012
  Purpose

The purpose of the study is to learn whether or not cocoa has a beneficial effect on blood flow to the brain in older subjects with diabetes mellitus or hypertension (high blood pressure). We hypothesize that cocoa, which contains flavanols (a type of polyphenol), may help to promote blood flow to the brain in older people with diabetes or hypertension.


Condition Intervention
Hypertension
Diabetes
Dietary Supplement: cocoa

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Flavanol-Rich Cocoa, Vascular Responses and Mechanisms

Resource links provided by NLM:


Further study details as provided by Brigham and Women's Hospital:

Primary Outcome Measures:
  • functional transcranial doppler measures [ Time Frame: 1 month ] [ Designated as safety issue: No ]

Estimated Enrollment: 66
Study Start Date: January 2009
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: flavanol-rich cocoa Dietary Supplement: cocoa
two servings of cocoa daily for one month
Other Name: Cocoa Pro
Placebo Comparator: flavanol-poor cocoa Dietary Supplement: cocoa
two servings of cocoa daily for one month
Other Name: Cocoa Pro

  Eligibility

Ages Eligible for Study:   65 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • diabetes and/or hypertension

Exclusion Criteria:

  • alzheimers disease, dementia, stroke, recent angina or heart attack
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00825695

Locations
United States, Massachusetts
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
Sponsors and Collaborators
Brigham and Women's Hospital
MasterFoods
Investigators
Principal Investigator: Naomi D. Fisher, MD Brigham and Women's Hospital
  More Information

No publications provided

Responsible Party: Naomi DL Fisher, MD, Principal Investigator, Brigham and Women's Hospital
ClinicalTrials.gov Identifier: NCT00825695     History of Changes
Other Study ID Numbers: P-001936, 1RO1HL089570
Study First Received: January 20, 2009
Last Updated: April 20, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Hypertension
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on April 16, 2014